194 related articles for article (PubMed ID: 33091232)
21. A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2.
Gu K; Qian D; Qin H; Cui C; Fernando WCHA; Wang D; Wang J; Cao K; Chen M
Pflugers Arch; 2021 Feb; 473(2):219-229. PubMed ID: 33449212
[TBL] [Abstract][Full Text] [Related]
22. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
[TBL] [Abstract][Full Text] [Related]
24. Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression.
Szendrey J; Lamothe SM; Vanner S; Guo J; Yang T; Li W; Davis J; Joneja M; Baranchuk A; Zhang S
Cardiovasc Res; 2019 Aug; 115(10):1500-1511. PubMed ID: 30544220
[TBL] [Abstract][Full Text] [Related]
25. The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C.
McPate MJ; Duncan RS; Milnes JT; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2005 Aug; 334(2):441-9. PubMed ID: 16011830
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
[TBL] [Abstract][Full Text] [Related]
27. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
[TBL] [Abstract][Full Text] [Related]
28. Multiple mechanisms underlie reduced potassium conductance in the p.T1019PfsX38 variant of hERG.
Al Salmani MK; Tavakoli R; Zaman W; Al Harrasi A
Physiol Rep; 2022 Jul; 10(14):e15341. PubMed ID: 35854468
[TBL] [Abstract][Full Text] [Related]
29. Fentanyl-Induced Block of hERG Channels Is Exacerbated by Hypoxia, Hypokalemia, Alkalosis, and the Presence of hERG1b.
Tschirhart JN; Zhang S
Mol Pharmacol; 2020 Oct; 98(4):508-517. PubMed ID: 32321735
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic Approach to Defective Protein Trafficking in the E637K-hERG Mutant with PD-118057 and Thapsigargin.
Mao H; Lu X; Karush JM; Huang X; Yang X; Ba Y; Wang Y; Liu N; Zhou J; Lian J
PLoS One; 2013; 8(6):e65481. PubMed ID: 23840331
[TBL] [Abstract][Full Text] [Related]
31. Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism.
Malak OA; Gluhov GS; Grizel AV; Kudryashova KS; Sokolova OS; Loussouarn G
J Biol Chem; 2019 Apr; 294(16):6506-6521. PubMed ID: 30808709
[TBL] [Abstract][Full Text] [Related]
32. Two mutations at different positions in the CNBH domain of the hERG channel accelerate deactivation and impair the interaction with the EAG domain.
Kume S; Shimomura T; Tateyama M; Kubo Y
J Physiol; 2018 Oct; 596(19):4629-4650. PubMed ID: 30086184
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue.
Helliwell MV; Zhang Y; El Harchi A; Dempsey CE; Hancox JC
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765012
[No Abstract] [Full Text] [Related]
34. The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C.
Zhang YH; Colenso CK; Sessions RB; Dempsey CE; Hancox JC
Biochim Biophys Acta; 2011 Oct; 1808(10):2477-87. PubMed ID: 21777565
[TBL] [Abstract][Full Text] [Related]
35. Extracellular protons accelerate hERG channel deactivation by destabilizing voltage sensor relaxation.
Shi YP; Thouta S; Cheng YM; Claydon TW
J Gen Physiol; 2019 Feb; 151(2):231-246. PubMed ID: 30530765
[TBL] [Abstract][Full Text] [Related]
36. Refinement of a cryo-EM structure of hERG: Bridging structure and function.
Khan HM; Guo J; Duff HJ; Tieleman DP; Noskov SY
Biophys J; 2021 Feb; 120(4):738-748. PubMed ID: 33476597
[TBL] [Abstract][Full Text] [Related]
37. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
38. Impact of the whole-cell patch-clamp configuration on the pharmacological assessment of the hERG channel: trazodone as a case example.
Rodriguez-Menchaca AA; Ferrer T; Navarro-Polanco RA; Sanchez-Chapula JA; Moreno-Galindo EG
J Pharmacol Toxicol Methods; 2014; 69(3):237-44. PubMed ID: 24412489
[TBL] [Abstract][Full Text] [Related]
39. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
Gianulis EC; Trudeau MC
J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
[TBL] [Abstract][Full Text] [Related]
40. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.
Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A
Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
